ASE · Medical - Instruments & Supplies

INFU (INFU) Stock

$12.10 -0.41% ASE: INFU Healthcare

Valuation

MetricValue
Price$12.10
Market Cap$244.20M
P/E Ratio32.90
P/B Ratio3.61
P/S Ratio1.39
EPS (TTM)$0.31
52-Week High$12.47
52-Week Low$5.38
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE12.28%
ROA6.93%
ROCE20.69%
Gross Margin7.69%
Operating Margin8.39%
Net Margin5.56%
Debt/Equity0.39
Current Ratio1.80

Annual Financials (USD)

Metric20212022202320242025
Revenue$102.0M$110.0M$126.0M$135.0M$143.0M
Operating Profit$3.0M$2.0M$4.0M$7.0M$12.0M
Net Profit$1.0M$0$1.0M$2.0M$7.0M
EPS$0.06$0.00$0.04$0.11$0.31
Op Margin2.8%1.5%3.3%5.1%8.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$98.0M$99.0M$103.0M$104.0M$101.0M
Total Liabilities$49.0M$51.0M$51.0M$46.0M$43.0M
Cash$0$0$0$1.0M$3.0M
Borrowings$37.0M$37.0M$35.0M$28.0M$3.0M

Latest News

Are Investors Undervaluing InfuSystems Holdings (INFU) Right Now? Zacks · Jun 29, 2026 InfuSystems Holdings (INFU) Soars 11.1%: Is Further Upside Left in the Stock? Zacks · Jun 29, 2026 Should Value Investors Buy InfuSystems Holdings (INFU) Stock? Zacks · Jun 12, 2026 Does InfuSystems Holdings (INFU) Have the Potential to Rally 62.61% as Wall Street Analysts Expect? Zacks · Jun 5, 2026 Here is Why Growth Investors Should Buy InfuSystems Holdings (INFU) Now Zacks · Jun 4, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$18.0M$18.0M$11.0M$20.0M$24.0M
Investing Cash Flow$-38.0M$-27.0M$-18.0M$-31.0M$-7.0M
Financing Cash Flow$-1.0M$-6.0M$0$-2.0M$-11.0M
Net Cash Flow$-9.0M$0$0$0$3.0M
Free Cash Flow$2.0M$2.0M$0$3.0M$24.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA8.23
FCF Yield10.29%
Quick Ratio1.80
Interest Coverage12.00
Return 1Y63.81%
Return 3Y-9.72%
Return 5Y-50.22%

Ownership

Insiders Held7.15%
Institutions Held79.13%
Institutions Float Held85.22%
Institutional HolderSharesReport Date
Minerva Advisors LLC1,204,1052026-03-31
Vanguard Capital Management LLC860,2632026-03-31
Punch & Associates Investment Management, Inc.837,9252026-03-31
First Eagle Investment Management, LLC721,3712026-03-31
Acadian Asset Management. LLC634,0442026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ELMD $27.10 -3.11% 32.25 $224.39M 0.00%
HSDT $2.09 -5.43% -1.25 $122.03M 0.00%
IVAInventiva S.A. $4.47 +1.59% -2.04 $232.36M 0.00%
KRMD $3.30 +0.00% -67.33 $151.58M 0.00%
NNOX $0.79 -2.66% -1.56 $54.70M 0.00%

About INFU

INFU is led by CEO Carrie A. Lachance, employs 502 people, headquartered in US, publicly traded since 2007.

INFU stock trades at $12.10 with a market capitalization of $244.20M. The stock is valued at a price-to-earnings (P/E) ratio of 32.90, price-to-book of 3.61, price-to-sales of 1.39. Over the past 52 weeks the stock has ranged between $5.38 and $12.47, and currently trades 3.0% below its 52-week high.

On profitability, INFU generates a return on equity (ROE) of 12.28%, above the typical market average, return on capital employed of 20.69%, an operating margin of 8.39%, a net profit margin of 5.56%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides